ATE152725T1 - Silylierte acetylcholinesterase inhibitoren - Google Patents
Silylierte acetylcholinesterase inhibitorenInfo
- Publication number
- ATE152725T1 ATE152725T1 AT94908615T AT94908615T ATE152725T1 AT E152725 T1 ATE152725 T1 AT E152725T1 AT 94908615 T AT94908615 T AT 94908615T AT 94908615 T AT94908615 T AT 94908615T AT E152725 T1 ATE152725 T1 AT E152725T1
- Authority
- AT
- Austria
- Prior art keywords
- silylated
- acetylcholinesterase inhibitors
- compounds
- methods
- acetylcholinesterase
- Prior art date
Links
- 239000000544 cholinesterase inhibitor Substances 0.000 title abstract 2
- 206010012289 Dementia Diseases 0.000 abstract 1
- 150000001491 aromatic compounds Chemical class 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 230000003412 degenerative effect Effects 0.000 abstract 1
- 230000000694 effects Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
- C07F7/02—Silicon compounds
- C07F7/08—Compounds having one or more C—Si linkages
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
- C07F7/02—Silicon compounds
- C07F7/08—Compounds having one or more C—Si linkages
- C07F7/0803—Compounds with Si-C or Si-Si linkages
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Neurosurgery (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Hospice & Palliative Care (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Psychiatry (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Steroid Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Polysaccharides And Polysaccharide Derivatives (AREA)
- Enzymes And Modification Thereof (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP93400385A EP0611769A1 (de) | 1993-02-16 | 1993-02-16 | Silytierte acetylcholinesterase Inhibitoren |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE152725T1 true ATE152725T1 (de) | 1997-05-15 |
Family
ID=8214682
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT94908615T ATE152725T1 (de) | 1993-02-16 | 1994-01-25 | Silylierte acetylcholinesterase inhibitoren |
Country Status (19)
| Country | Link |
|---|---|
| EP (2) | EP0611769A1 (de) |
| JP (1) | JP3516955B2 (de) |
| KR (1) | KR100336547B1 (de) |
| CN (1) | CN1043575C (de) |
| AT (1) | ATE152725T1 (de) |
| AU (1) | AU672885B2 (de) |
| CA (1) | CA2154870C (de) |
| DE (1) | DE69403068T2 (de) |
| DK (1) | DK0684951T3 (de) |
| ES (1) | ES2104358T3 (de) |
| FI (1) | FI111461B (de) |
| GR (1) | GR3024151T3 (de) |
| HU (1) | HUT72736A (de) |
| IL (1) | IL108623A0 (de) |
| MX (1) | MX9401175A (de) |
| NO (1) | NO305517B1 (de) |
| NZ (1) | NZ262247A (de) |
| WO (1) | WO1994019356A1 (de) |
| ZA (1) | ZA94925B (de) |
Families Citing this family (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0627400A1 (de) * | 1993-06-04 | 1994-12-07 | Merrell Dow Pharmaceuticals Inc. | Aromatische Inhibitoren von Acetylcholinesterase |
| CN100431539C (zh) * | 2004-01-12 | 2008-11-12 | 和泓生物技术（上海）有限公司 | 乙酰胆碱酯酶抑制剂在制备治疗帕金森病药物中的应用 |
| WO2008055945A1 (en) | 2006-11-09 | 2008-05-15 | Probiodrug Ag | 3-hydr0xy-1,5-dihydr0-pyrr0l-2-one derivatives as inhibitors of glutaminyl cyclase for the treatment of ulcer, cancer and other diseases |
| ATE554085T1 (de) | 2006-11-30 | 2012-05-15 | Probiodrug Ag | Neue inhibitoren von glutaminylcyclase |
| EP2117540A1 (de) | 2007-03-01 | 2009-11-18 | Probiodrug AG | Neue verwendung von glutaminyl-cyclase-hemmern |
| JP5667440B2 (ja) | 2007-04-18 | 2015-02-12 | プロビオドルグ エージー | グルタミニルシクラーゼ阻害剤としてのチオ尿素誘導体 |
| SG178953A1 (en) | 2009-09-11 | 2012-04-27 | Probiodrug Ag | Heterocylcic derivatives as inhibitors of glutaminyl cyclase |
| EP2533645B1 (de) | 2010-02-09 | 2016-07-27 | The Johns Hopkins University | Verfahren und zusammensetzungen zur verbesserung von kognitiven funktionen |
| US9181233B2 (en) | 2010-03-03 | 2015-11-10 | Probiodrug Ag | Inhibitors of glutaminyl cyclase |
| AU2011226074B2 (en) | 2010-03-10 | 2015-01-22 | Vivoryon Therapeutics N.V. | Heterocyclic inhibitors of glutaminyl cyclase (QC, EC 2.3.2.5) |
| US8541596B2 (en) | 2010-04-21 | 2013-09-24 | Probiodrug Ag | Inhibitors |
| ES2570167T3 (es) | 2011-03-16 | 2016-05-17 | Probiodrug Ag | Derivados de benzimidazol como inhibidores de glutaminil ciclasa |
| EP2919788A4 (de) | 2012-11-14 | 2016-05-25 | Univ Johns Hopkins | Verfahren und zusammensetzungen zur behandlung von schizophrenie |
| EP2968237A4 (de) | 2013-03-15 | 2016-08-31 | Univ Johns Hopkins | Verfahren und zusammensetzungen zur verbesserung der kognitiven funktion |
| DK2968220T3 (da) | 2013-03-15 | 2021-06-14 | Agenebio Inc | Fremgangsmåder og sammensætninger til forbedring af kognitiv funktion |
| BR112017025031B1 (pt) | 2015-05-22 | 2023-03-21 | Agenebio, Inc | Composições farmacêuticas de liberação prolongada de levetiracetam |
| ES2812698T3 (es) | 2017-09-29 | 2021-03-18 | Probiodrug Ag | Inhibidores de glutaminil ciclasa |
| CN112047973B (zh) * | 2019-06-06 | 2022-11-18 | 上海科技大学 | 一种大麻素类化合物，其制备方法、组合物和用途 |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0403713A1 (de) * | 1989-06-22 | 1990-12-27 | Merrell Dow Pharmaceuticals Inc. | Acetylcholinesterase-Inhibitoren |
-
1993
- 1993-02-16 EP EP93400385A patent/EP0611769A1/de not_active Withdrawn
-
1994
- 1994-01-25 NZ NZ262247A patent/NZ262247A/en unknown
- 1994-01-25 DE DE69403068T patent/DE69403068T2/de not_active Expired - Lifetime
- 1994-01-25 DK DK94908615.1T patent/DK0684951T3/da active
- 1994-01-25 EP EP94908615A patent/EP0684951B1/de not_active Expired - Lifetime
- 1994-01-25 ES ES94908615T patent/ES2104358T3/es not_active Expired - Lifetime
- 1994-01-25 AU AU61641/94A patent/AU672885B2/en not_active Ceased
- 1994-01-25 HU HU9502406A patent/HUT72736A/hu unknown
- 1994-01-25 WO PCT/US1994/000720 patent/WO1994019356A1/en active IP Right Grant
- 1994-01-25 CA CA002154870A patent/CA2154870C/en not_active Expired - Fee Related
- 1994-01-25 JP JP51897494A patent/JP3516955B2/ja not_active Expired - Fee Related
- 1994-01-25 AT AT94908615T patent/ATE152725T1/de active
- 1994-01-25 CN CN94191196A patent/CN1043575C/zh not_active Expired - Fee Related
- 1994-01-25 KR KR1019950703485A patent/KR100336547B1/ko not_active IP Right Cessation
- 1994-02-10 ZA ZA94925A patent/ZA94925B/xx unknown
- 1994-02-11 IL IL10862394A patent/IL108623A0/xx unknown
- 1994-02-15 MX MX9401175A patent/MX9401175A/es not_active Application Discontinuation
-
1995
- 1995-08-15 NO NO953201A patent/NO305517B1/no unknown
- 1995-08-15 FI FI953851A patent/FI111461B/fi not_active IP Right Cessation
-
1997
- 1997-07-16 GR GR970401801T patent/GR3024151T3/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| IL108623A0 (en) | 1994-05-30 |
| DK0684951T3 (da) | 1997-05-26 |
| DE69403068D1 (en) | 1997-06-12 |
| NO953201L (no) | 1995-08-15 |
| ES2104358T3 (es) | 1997-10-01 |
| GR3024151T3 (en) | 1997-10-31 |
| EP0684951B1 (de) | 1997-05-07 |
| WO1994019356A1 (en) | 1994-09-01 |
| HUT72736A (en) | 1996-05-28 |
| AU6164194A (en) | 1994-09-14 |
| CA2154870A1 (en) | 1994-09-01 |
| JP3516955B2 (ja) | 2004-04-05 |
| EP0684951A1 (de) | 1995-12-06 |
| DE69403068T2 (de) | 1997-12-11 |
| JPH08507059A (ja) | 1996-07-30 |
| NO305517B1 (no) | 1999-06-14 |
| FI111461B (fi) | 2003-07-31 |
| KR960701068A (ko) | 1996-02-24 |
| EP0611769A1 (de) | 1994-08-24 |
| MX9401175A (es) | 1994-08-31 |
| FI953851A0 (fi) | 1995-08-15 |
| NZ262247A (en) | 1996-01-26 |
| CN1043575C (zh) | 1999-06-09 |
| CA2154870C (en) | 1998-10-27 |
| CN1117733A (zh) | 1996-02-28 |
| FI953851A (fi) | 1995-08-15 |
| NO953201D0 (no) | 1995-08-15 |
| ZA94925B (en) | 1994-08-25 |
| AU672885B2 (en) | 1996-10-17 |
| KR100336547B1 (ko) | 2002-11-02 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK0701546T3 (da) | Aromatiske acetylchlolinesteraseinhibitorer | |
| DK0684951T3 (da) | Silylerede acetylcholinesterase-inhibitorer | |
| DE69427869D1 (de) | Botulinumtoxine zur behandlung von hyperhydrosis | |
| MX9304638A (es) | Composicion para tratar e inhibir las ulceras gastricas y duodenales. | |
| ES2106965T3 (es) | Nuevas 4-aza-5alfa-androstan-3-onas 7beta-sustituidas como inhibidores de 5alfa-reductasa. | |
| HUT71550A (en) | Pharmaceutical agents containing quinuclidine, piperidine or azanorbornane derivatives for treatment of emesis | |
| DE69405711D1 (de) | Behandlung von rueckstandsoel | |
| IN167848B (de) | ||
| DK0655243T3 (da) | Melatoninderivater til anvendelse ved behandling af søvnlidelser | |
| DE69432626D1 (de) | Melatonin-Derivate zur Verwendung in der Behandlung von Desynchronisierungs-Erkankungen | |
| NO982582L (no) | Fremgangsmaate for behandling av smerte | |
| ITMI930571A1 (it) | Procedimento ed apparecchiatura per l'analisi di composti volatili organici. | |
| ATE140228T1 (de) | Hydroxymethyl-indolizidine und -chinolizidine | |
| DE59305800D1 (de) | Werkzeug zur behandlung von oberflächen von bauteilen | |
| ATE262527T1 (de) | Zur vorbeugung oder behandlung von östrogenabhängigen krankheiten nützliche pyrrolo(2.1.5-cd)indolizin-derivate | |
| FI933169A (fi) | Transuretraalinen laserhoitomenetelmä |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification | ||
| EEIH | Change in the person of patent owner |